semaglutide atrial fibrillation Atrial Fibrillation and Semaglutide Effects in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Program

Glycemic control and atrial fibrillation: an intricate relationship, yet under investigation | Cardiovascular Diabetology

29.34

★★★★☆4.8 (126)

Our recent meta-analysis published in @hrs_journal suggests lower atrial arrhythmia recurrence after AF ablation with Semaglutide use, highlighting metabolic optimization as a promising rhythm-control strategy. @OBHCardiology @3absatar74 @HMakadmaMD

27.11

★★★★★4.9 (98)

Atrial Fibrillation in Diabetes: Pathogenesis and Targeted Rhythm Control Strategies

27.79

★★★★★5.0 (157)

AF and Ozempic

29.44

★★★★★4.7 (84)

Popular weight loss and anti-inflammatory drugs may help prevent common heart rhythm disorder A new BGU-led study published in Europace found that the GLP-1 drug semaglutide and the anti-inflammatory drug colchicine may

26.20

★★★★★4.9 (203)

In a 68-year-old obese male (BMI ~36) with a history of atrial fibrillation controlled by two ablations, a permanent pacemaker, a Watchman left‑atrial appendage closure device, chronic obstructive pulmonary disease, and chronic

25.82

★★★★★5.0 (176)

Impact of GLP-1 Receptor Agonist Therapy on Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients: A Real-World Data Analysis

21.04

★★★★★4.8 (132)